This article showcases our top picks for the best Seoul based Therapeutics companies. These startups and companies are taking a variety of approaches to innovating the Therapeutics industry, but are all exceptional companies well worth a follow.
We tried to pick companies across the size spectrum from cutting edge startups to established brands.
We selected these startups and companies for exceptional performance in one of these categories:
- Innovation
- Innovative ideas
- Innovative route to market
- Innovative product
- Growth
- Exceptional growth
- Exceptional growth strategy
- Management
- Societal impact
Top Seoul Therapeutics Startups
Data sourced from Crunchbase and SemRush.
AffyXell Therapeutics
Crunchbase Website Twitter Facebook Linkedin
AffyXell Therapeutics develops novel mesenchymal stem cell therapies.
MEDIHERE
Crunchbase Website Twitter Facebook Linkedin
A telehealth platform connecting patients whose mother tongue is not English with doctors who can speak their mother tongue.
Kaipharm
Crunchbase Website Twitter Facebook Linkedin
KaiPharm is an AI-driven drug discovery company with proprietary virtual drug-screening technology and drug-induced transcriptome data.
AbClon
Crunchbase Website Twitter Facebook Linkedin
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden.
ImmunoForge
Crunchbase Website Twitter Facebook Linkedin
ImmunoForge is a developer of a new drug intended for treating sarcopenia and cancer.
ICM
Crunchbase Website Twitter Facebook Linkedin
ICM is a gene therapy developer company for incurable diseases.
Kolon Life Science
Crunchbase Website Twitter Facebook Linkedin
Kolon Life Science is a pharmaceutical business and environmental business.
ProCell Therapeutics
Crunchbase Website Twitter Facebook Linkedin
ProCell Therapeutics is a research on developing new drugs and functional ingredients / cosmetics
Kangstem Biotech
Crunchbase Website Twitter Facebook Linkedin
Kangstem Biotech researches and develops advanced bio-pharmaceuticals that involve stem cell therapies.